Molecular therapy for pulmonary hypertension: MiRNA-222 suppresses pulmonary hypertension via down regulation of its target gene, 08/March/2015, 22.31

Vitamin-based therapy for Metastatic tumors: 1,25-dihydroxyvitamin D decreases the expression of PD-1, a suppressor of activation of T-cells, and activates the immune system via down regulation of its target gene, 8/March/2015, 22.28
March 8, 2015
Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of tumor suppressor PDCD4 via down regulation of its target gene, 8/March/2015, 22.34
March 8, 2015
Show all

A recent study from the from the Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States of America shows that “High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. This study was published in the 8 Feb’13  issue of the Journal “Molecular Medicine”  by Drs. Bauer PMBauer EM and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular  therapy for pulmonary hypertension: MiRNA-222 suppresses pulmonary hypertension via down regulation of its target gene. This study suggests, for the first time, that MiRNA-222, by decreasing the expression of its target gene, may: (1) decrease Right ventricular systolic pressure, and (2) inhibit thickening of the pulmonary artery wall. Together, pharmacological formulations encompassing “MiRNA-222 or its activators may be used to treat patients suffering from pulmonary hypertension.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Molecular  therapy for pulmonary hypertension: MiRNA-222 suppresses pulmonary hypertension via down regulation of its target gene, 08/March/2015,  22.31,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How MiRNA-222 stifles pulmonary hypertension

Comments are closed.